Approved Study Database

Ref. No. Scientific Title Principal investigator
2014.482 A Phase 2, Multi-Center, Randomised, Double-Blind, Ascending-Dose, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of Fostamatinib in the Treatment of IgA Nephropathy Prof. SZETO Cheuk Chun
2014.480 Retrospective study on the outcomes after primary tubularized incised plate urethroplasty for mid-shaft and proximal hypospadias in children Dr Tam Yuk Him
2014.477 Phase II Trial of Individualized Lung Tumor Stereotactic Ablative Radiotherapy (iSABR) Dr. MOK Florence Siu Ting
2014.474 Validation of the Cantonese version of Columbia Suicide Severity Rating Scale (C-SSRS) Dr. WONG Wing Ho
2014.473 Aerobic and mind body exercise interventions for adults with anxiety and depressive disorders under primary care settings in Hong Kong – a randomized control trial. Prof Lam Linda Chiu-wa
2014.472 The Effects of Graduated Compression Tights on Hemodynamic Responses of Head-up Tilt Testing in Healthy Subjects Mr. LEE Daniel Chi Wo
2014.471 Pathway to care and three-year outcome comparison of extended early intervention service and standard psychiatric care for adults presenting with first-episode psychosis Dr. WONG Yip Chau
2014.470 Using Text Mining Method to Understand Incident Reporting Structures Using Advance Incidents Reporting System (AIRS) v.3 Dr So Hing Yu
2014.469 A database study to investigate the epidemiology of Clostridium difficile infections in Hong Kong Dr. WONG Sunny Hei
2014.468 Establishments of Chinese kidney tissue bank for molecular and functional studies of benign and malignant kidney diseases Prof. NG Chi Fai
2014.467 Urinary metabolic prognostic markers in prostate cancer Prof. NG Chi Fai
2014.466 Interventional study on reducing irrational use of antibiotics in children with upper respiratory infections (URIs) in rural Guangxi, China Prof. WEI Xiaolin
2014.465 Study of treatment support in relation to treatment outcome of Multi-drug resistant tuberculosis (MDR) Prof WEI Xiaolin
2014.464 Diagnostic and Prognostic role of USCOM in Adult Patients with Heart Failure: A Prospective Observational Study Prof. GRAHAM Colin
2014.463 A Double-masked, Placebo-controlled Study with Open-label Period to Evaluate the Efficacy and Safety of MEDI-551 in Adult Subjects with Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders Dr. LAU Alexander Yuk Lun
2014.462 Phase II Trial of the Addition of Gemcitabine to 131I-MIBG Therapy in Paediatric Patients with Relapsed or Progressive Neuroblastoma Dr. LI Chi Kong
2014.461 Should aspirin be recommended for the prevention of cancer Dr. TSOI Kelvin Kam Fai
2014.460 A Retrospective Study to Assess the Role of Prophylactic Anti-viral Therapies for Patients with CD20+ Lymphoma Receiving Anti-B cell Therapies Prof. YEO Winnie
2014.459 A randomized, controlled trial of the discontinuation of a standard maintenance therapy of oral aminosalicylic acid in ulcerative colitis patients in long-term remission Prof Ng Siew Chien
2014.458 A Prospective Study of Transcutaneous Neuromuscular Electrical Stimulation Swallowing Therapy (VitalStim) in Post-irradiated Nasopharyngeal Carcinoma Patients with Symptomatic Dysphagia Dr. KU Ka Ming
2014.457 A prospective, multicenter, randomized, double blind, placebo-controlled, 2-parallel groups, phase 3 study to compare the efficacy and safety of masitinib in combination with FOLFIRI (irinotecan, 5-fluorouracil and folinic acid) to placebo in combination with FOLFIRI in second line treatment of patients with metastatic colorectal cancer Prof. LOONG Herbert
2014.455 Multi-Center Study of In Vitro Diagnostic Devices for the Detection of Influenza A, Influenza B, and RSV Professor Chan Paul KS
2014.453 Acute Substernal Defibrillation (ASD) Study Dr. CHAN Joseph Yat Sun
2014.452 MSBase: An international Registry dedicated to evaluating outcomes data in Multiple Sclerosis (MS) Dr. LAU Alexander Yuk-lun
2014.451 A Phase IV Post-market, Observational, Retrospective & Prospective, Multi-centre Study of Lacosamide (Vimpat®) in Refractory, Partial-Onset Epilepsy patients in Hong Kong Dr. LEUNG Howan
2014.450 A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin® (pyridoxamine dihydrochloride) in Subjects with Nephropathy Due to Type 2 Diabetes (PIONEER) Dr. OZAKI Risa
2014.449 Placental iodine and thyroxine transport - relationship with pregnancy complications and perinatal outcome. Mr. Ng Yu Tai Russell
2014.448 Determination of labor progression patterns using non-invasive, ultrasound based, multiple parameters in Chinese population Dr. CHOR Chung Ming
2014.446 “Community Acquired Central Nervous System Infections” (CACNSI) survey Dr. WONG Bonnie Chun Kwan
2014.445 Establish a national registry to search for the risk factors, etiology, and neurodegenerative progression of REM sleep behavior disorder Prof. ZHANG Jihui
2014.444 Cost-Effectiveness Analysis of XELOX versus FOLFOX-4 regimens with or without Bevacizumab in the first line management of metastatic colorectal cancer (MCRC) in Hong Kong Prof. Lee Vivian Wing Yan
2014.443 A MULTICENTRE RANDOMIZED PROGRAM BY USING A DIABETIC KIDNEY DISEASE (DKD) REGISTRY TO TREAT TO MULTIPLE TARGETS (TMT) (DKD-TMT) Dr. TSANG Chiu Chi
2014.442 MicroRNAs for Liver Disease Progression Determination of Non-invasive, Blood-Based Biomarkers for the Prognosis of Chronic Liver Disease Prof. WONG Wai Sun
2014.441 A MULTICENTRE RANDOMIZED PROGRAM BY USING A DIABETIC KIDNEY DISEASE (DKD) REGISTRY TO TREAT TO MULTIPLE TARGETS (TMT) (DKD-TMT) Dr. LUK Andrea
2014.440 A double-blind, randomised, placebo controlled Phase III study of nintedanib plus best supportive care (BSC) versus placebo plus BSC in patients with colorectal cancer refractory to standard therapies. Prof. MA Brigette
2014.438 Apps to Quit: Ecological Momentary Assessment-Intervention for Psychotropic Substance Abusers. A Pilot Study Prof Tang Wai Kwong
2014.437 Effectiveness of peer-led Wellness Recovery Action Planning (WRAP) on Persons in recovery and youth people in Hong Kong Prof. MAK Winnie Wing Sze
2014.436 Validation of Brief Assessment of Prospective Memory (Hong Kong Chinese version) for older adults with cognitive impairment and early dementia Ms Law Siu Tuen, Daphne
2014.435 Molecular epidemiology and evolutionary genetics study of Neisseria gonorrhoeae with decreased susceptibility to cephalosporins between Hong Kong and Guangdong asso. Prof. Harwell Joseph
2014.434 Sulfur Amino Acids as Risk Factors for Obesity and Related Morbidities in Older Chinese People Prof. KWOK Timothy
2014.433 Comparing mindfulness meditation and Buddhist meditation on well-being among university students: A randomized controlled trial Mr. TANG Chung Sing
2014.432 A study of the hemodynamics of aortic dissection before and after endovascular repair Prof. YU Simon
2014.431 A study of the hemodynamics of narrowed head and neck vessels Prof. YU Simon
2014.430 A prospective cohort study on the effectiveness of psychological preparation conducted by Hospital Play Specialist in reducing need of sedation and level of anxiety in paediatric patients who undergo MRI Ms LOY Tammy Sze wah
2014.429 Circadian gene expression alteration of insomnia disorder in an ex vivo cellular model: a pilot study Prof. ZHANG Jihui
2014.428 Mechanisms of circadian rhythms in the progression of REM sleep behavior disorder towards neurodegeneration Prof. ZHANG Jihui
2014.427 Does repetitive, assistive sit-to-stand training facilitate the independence in sit-to-stand? A randomized controlled trial Mr Ng Chee Man
2014.426 A STUDY TO EVALUATE THE EFFECT OF BTI320 (SUGARDOWN®) ON POST-PRANDIAL HYPERGLYCAEMIA IN HIGH RISK CHINESE SUBJECTS WITH PRE-DIABETES Dr. LUK Andrea On Yan
2014.425 A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects with Type 2 Diabetes and Nephropathy - SONAR: Study Of Diabetic Nephropathy with Atrasentan Dr. OZAKI Risa
2014.424 DECLARE Dapagliflozin Effect on CardiovascuLAR Events A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 Diabetes Prof. MA Ronald Ching Wan

Page 143 of 265.